FIDUCIARY TRUST CO - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 56 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
FIDUCIARY TRUST CO ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$606,304
+34.5%
136,5550.0%0.01%
+37.5%
Q2 2023$450,632
+15.8%
136,5550.0%0.01%
+14.3%
Q1 2023$389,182
-60.9%
136,5550.0%0.01%
-63.2%
Q4 2022$994,120
-7.3%
136,555
+3.1%
0.02%
-17.4%
Q3 2022$1,072,000
+65.2%
132,4720.0%0.02%
+64.3%
Q2 2022$649,000
-79.3%
132,4720.0%0.01%
-75.0%
Q1 2022$3,133,000
+33.7%
132,4720.0%0.06%
+43.6%
Q4 2021$2,343,000
-35.7%
132,472
+2.5%
0.04%
-40.0%
Q3 2021$3,645,000
+176.1%
129,215
+2.6%
0.06%
+150.0%
Q2 2021$1,320,000
-10.3%
125,999
+0.8%
0.03%
-13.3%
Q1 2021$1,472,000
+0.5%
124,9990.0%0.03%
-3.2%
Q4 2020$1,464,000
+47.7%
124,9990.0%0.03%
+34.8%
Q3 2020$991,000
-56.6%
124,9990.0%0.02%
-59.6%
Q2 2020$2,286,000
+53.2%
124,9990.0%0.06%
+32.6%
Q1 2020$1,492,000
+348.0%
124,999
+525.0%
0.04%
+437.5%
Q4 2019$333,000
+404.5%
20,000
+100.0%
0.01%
+300.0%
Q3 2019$66,00010,0000.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$19,415,0007.94%
TRV GP IV, LLC 2,343,154$11,481,0007.55%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 949$193,741,0002.02%
Logos Global Management LP 1,950,000$9,555,0001.75%
COWEN AND COMPANY, LLC 2,385,885$11,691,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,355,624$16,443,0000.62%
ACUTA CAPITAL PARTNERS, LLC 200,000$980,0000.55%
RTW INVESTMENTS, LP 3,961,194$19,410,0000.50%
Parkman Healthcare Partners LLC 262,689$1,287,0000.47%
Deep Track Capital, LP 1,000,000$4,900,0000.32%
View complete list of FULCRUM THERAPEUTICS INC shareholders